A comprehensive understanding of the transcriptional alterations induced by BRD4 inhibition could elucidate the anti-tumor mechanisms of BET inhibitors and improve the efficacy of BRD4-targeted therapies in cancer treatment [5, 8, 9]. The gene discussed is DNER; the disease is neoplasm.